TY  - CHAP
M1  - Book, Section
TI  - The impact of finerenone in stage 3 and 4 diabetic kidney disease—the FIDELIO-DKD trial.
A1  - Havrda, Dawn
A2  - Linn, William D.
Y1  - 2016
N1  - 
T2  - Topics in Evidence-Based Pharmacy Practice
AB  - 
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/20
UR  - accesspharmacy.mhmedical.com/updatesContent.aspx?gbosid=594028
ER  -